Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shohei Nishimon, Naoya Nishino & Seiji Nishino. (2021) Advances in the pharmacological management of non-24-h sleep-wake disorder. Expert Opinion on Pharmacotherapy 22:8, pages 1039-1049.
Read now
Read now
Articles from other publishers (5)
Haozhe Yu, Qicong Wang, Wenyu Wu, Weizhen Zeng & Yun Feng. (2021) Therapeutic Effects of Melatonin on Ocular Diseases: Knowledge Map and Perspective. Frontiers in Pharmacology 12.
Crossref
Crossref
Alexander Zakharov & Elena Khivintseva. 2020. Melatonin - The Hormone of Darkness and its Therapeutic Potential and Perspectives. Melatonin - The Hormone of Darkness and its Therapeutic Potential and Perspectives.
Josephine Arendt. (2019) Melatonin: Countering Chaotic Time Cues. Frontiers in Endocrinology 10.
Crossref
Crossref
Colm D. Andrews, Russell G. Foster, Iona Alexander, Sridhar Vasudevan, Susan M. Downes, Carl Heneghan & Annette Plüddemann. (2019) Sleep–Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical Therapies. Translational Vision Science & Technology 8:3, pages 49.
Crossref
Crossref
Maria Antonia Quera Salva, Sarah Hartley, Damien Léger & Yves A. Dauvilliers. (2017) Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management. Frontiers in Neurology 8.
Crossref
Crossref